Backed by the Zuckerbergs, Biohub is coordinating a $1.8 billion "Virtual Biology Initiative" to develop AI models that predict cell behavior and accelerate drug discovery. Funding comes from Meta, Google DeepMind, Isomorphic Labs, and the US Department of Energy. Commercial sponsors receive one-year exclusive data access, while government-funded portions are released publicly. The first standardized training dataset is expected within a year.
The initiative focuses on upgrading lab measurement technologies, expanding computational resources, and developing new data collection methods. These efforts aim to create a core data foundation for AI models capable of understanding cellular systems to ultimately cure or prevent human diseases. By addressing the critical data bottleneck in biological AI, the project seeks to establish an open global resource library enabling scientists to leverage AI for studying cellular mechanisms.
This investment marks deep collaboration among tech giants in building infrastructure for AI-driven biomedical research. By integrating data, laboratory equipment, and computing power, the initiative aims to significantly shorten drug development cycles. It will provide researchers worldwide with unprecedented high-quality biological data support, driving the broad application of AI in life sciences.